MAP2K1 ‐ driven mixed Langerhans cell histiocytosis, Rosai‐Dorfman‐Destombes disease and Erdheim‐Chester disease, clonally related to acute myeloid leukemia

Author(s):  
Arturo Bonometti ◽  
Giuseppina Ferrario ◽  
Antonina Parafioriti ◽  
Demostene Giardino ◽  
Federico Simonetti ◽  
...  
2020 ◽  
Vol Volume 13 ◽  
pp. 11689-11695
Author(s):  
Sotirios G Papageorgiou ◽  
Aspasia Divane ◽  
Maria Roumelioti ◽  
Christine Kottaridi ◽  
Anthi Bouchla ◽  
...  

Haematologica ◽  
2019 ◽  
Vol 104 (8) ◽  
pp. e373-e375 ◽  
Author(s):  
Armin Ghobadi ◽  
Christopher A. Miller ◽  
Tiandao Li ◽  
Michelle O’Laughlin ◽  
Yi-Shan Lee ◽  
...  

Cases Journal ◽  
2008 ◽  
Vol 1 (1) ◽  
Author(s):  
Khalid A Al-Anazi ◽  
Abdulrahman Alshehri ◽  
Hazza A Al-Zahrani ◽  
Fahad I Al-Mohareb ◽  
Irfan Maghfoor ◽  
...  

2004 ◽  
Vol 445 (4) ◽  
pp. 405-409 ◽  
Author(s):  
V. P. Andrade ◽  
C. C. V. Nemer ◽  
A. N. L. Prezotti ◽  
W. S. L. Goulart

2019 ◽  
Vol 23 (1) ◽  
pp. 48-53 ◽  
Author(s):  
Xiaolei Hao ◽  
Ruie Feng ◽  
Yalan Bi ◽  
Yuhan Liu ◽  
Chunde Li ◽  
...  

Erdheim-Chester disease (ECD) is a rare non–Langerhans cell form of histiocytosis that can affect the central nervous system. ECD predominantly affects adults, and only a few pediatric cases have been reported. The co-occurrence of ECD and Langerhans cell histiocytosis (LCH) is exceedingly rare. An 11-year-old boy, who was diagnosed with LCH 7 years previously, presented with multiple giant intracranial lesions. At the time of his initial diagnosis, only one intracranial lesion was observed, and it began to enlarge. Currently, up to 7 intracranial lesions can be observed in this patient. However, the diagnosis of ECD was not confirmed until this most recent open resection. The BRAF V600E mutation was detected in both LCH and ECD lesions. Dabrafenib therapy exhibited dramatic efficacy in this pediatric patient. This case represents the first successful application of dabrafenib in a pediatric patient with intracranial ECD lesions as well as mixed ECD and LCH. In this article, the authors describe the intricate diagnosis and treatment processes in this patient. Recent studies regarding treatment with BRAF inhibitors for neurological involvement in mixed ECD and LCH are also reviewed.


2020 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Suheyla Ocak ◽  
Zuhal Bayramoglu ◽  
Deniz Tugcu ◽  
Serap Karaman ◽  
Aysegul Unuvar ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document